Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization
Cancer Cell · 2024-05 · 42 (5) · 815-832.e12
DOI: 10.1016/j.ccell.2024.03.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2024-05. Verfasst von Wenying Wang und 40 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Amy Medical University), and The Key Labor…. Hauptthemen laut MEDLINE: Glioblastoma, Adrenomedullin, Brain Neoplasms, Tumor-Associated Macrophages. Die Arbeit wurde bisher 253-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China Stem Cell and Translational Research, Natural Science Foundation of Chongqing Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Monocyte-derived tumor-associated macrophages (Mo-TAMs) intensively infiltrate diffuse gliomas with remarkable heterogeneity. Using single-cell transcriptomics, we chart a spatially resolved transcriptional landscape of Mo-TAMs across 51 patients with isocitrate dehydrogenase (IDH)-wild-type glioblastomas or IDH-mutant gliomas. We characterize a Mo-TAM subset that is localized to the peri-necrotic niche and skewed by hypoxic niche cues to acquire a hypoxia response signature. Hypoxia-TAM destabilizes endothelial adherens junctions by activating adrenomedullin paracrine signaling, thereby stimulating a hyperpermeable neovasculature that hampers drug delivery in glioblastoma xenografts. Accordingly, genetic ablation or pharmacological blockade of adrenomedullin produced by Hypoxia-TAM restores vascular integrity, improves intratumoral concentration of the anti-tumor agent dabrafenib, and achieves combinatorial therapeutic benefits. Increased proportion of Hypoxia-TAM or adrenomedullin expression is predictive of tumor vessel hyperpermeability and a worse prognosis of glioblastoma. Our findings highlight Mo-TAM diversity and spatial niche-steered Mo-TAM reprogramming in diffuse gliomas and indicate potential therapeutics targeting Hypoxia-TAM to normalize tumor vasculature.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Amy Medical University), and The Key Laboratory of Tumor Immunopathology, The Ministry of Education of China, Ch…
- Department of Neurosurgery and Glioma Medical Research Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China.
- Britton Chance Center for Biomedical Photonics, Wuhan National Laboratory for Optoelectronics, and MoE Key Laboratory for Biomedical Photonics, School of Engineering Sciences, Huazhong University of Science and Technolo…
- Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing 400042, P.R. China.
Förderung
- National Key Research and Development Program of China Stem Cell and Translational Research
- Natural Science Foundation of Chongqing Municipality
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Army Medical University
- Natural Science Foundation Project of Chongqing
Zitieren
APA
Wang, W., Li, T., Cheng, Y., Li, F., Qi, S., Mao, M., Wu, J., Liu, Q., Zhang, X., Li, X., Zhang, L., Qi, H., Yang, L., Yang, K., He, Z., Ding, S., Qin, Z., Yang, Y., Yang, X., …, & Shi, Y. (2024). Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization. Cancer Cell, 42(5), 815-832.e12. https://doi.org/10.1016/j.ccell.2024.03.013
Vancouver
Wang W, Li T, Cheng Y, Li F, Qi S, Mao M, et al. Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization. Cancer Cell. 2024;42(5):815-832.e12. doi:10.1016/j.ccell.2024.03.013
BibTeX
@article{Wang2024,
author = {Wang, Wenying and Li, Tianran and Cheng, Yue and Li, Fei and Qi, Shuhong and Mao, Min and Wu, Jingjing and Liu, Qing and Zhang, Xiaoning and Li, Xuegang and Zhang, Lu and Qi, Haoyue and Yang, Lan and Yang, Kaidi and He, Zhicheng and Ding, Shuaishuai and Qin, Zhongyi and Yang, Ying and Yang, Xi and Luo, Chunhua and Guo, Ying and Wang, Chao and Liu, Xindong and Zhou, Lei and Liu, Yuqi and Kong, Weikai and Miao, Jingya and Ye, Shuanghui and Luo, Min and An, Lele and Wang, Lujing and Che, Linrong and Niu, Qin and Ma, Qinghua and Zhang, Xia and Zhang, Zhihong and Hu, Rong and Feng, Hua and Ping, Yi-Fang and Bian, Xiu-Wu and Shi, Yu},
title = {Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization},
journal = {Cancer Cell},
year = {2024},
volume = {42},
number = {5},
pages = {815--832.e12},
doi = {10.1016/j.ccell.2024.03.013}
}
EUVIMED